Escoffery Cam, Sun Juzhong, DeGroff Amy, Sharma Krishna, Masud Manal, Vu Thuy, Schlueter Dara, Hannon Peggy
Department of Behavioral, Social and Health Education Sciences, Rollins School of Public Health, 1518 Clifton Road5 Floor, Atlanta, NE, GA, 30322, United States.
TJFACT LLC, Atlanta, GA, United States.
Implement Sci Commun. 2025 Jul 29;6(1):79. doi: 10.1186/s43058-025-00759-0.
CDC's Colorectal Cancer Control Program (CRCCP) aims to increase colorectal cancer (CRC) screening prevalence by implementing evidence-based interventions (EBIs) in health system clinics partnering with the program. Program champions, as one of the key program components, are expected to facilitate the implementation of EBIs and support desired changes in many ways. Given limited information about the champions in clinical systems, this study investigated champion types, roles, and sustainability within the CRCCP.
This mixed methods, cross-sectional study included a survey of 205 respondents (health system and clinic staff) representing 303 clinics and 12 qualitative interviews of CRCCP award recipients and partnering clinics. The survey assessed clinic characteristics, EBI implementation, information about program champions, and sustainability. Interview topics included champion roles, benefits, turnover, and maintenance.
Champions worked at either the health system or clinic level. Among health systems, champions were quality improvement (QI) managers (48.5%), physicians (36.4%), or high-level administrators (27.3%). In clinics, champions were physicians (37.0%), QI managers (26.1%) or medical assistants (23.9%). Champions in both health systems and clinics were most often assigned the role (45.5% and 45.7%, respectively); yet clinic champions were more likely to naturally emerge than health system champions (26.1% vs. 15.2%). Among naturally emerging champions, 64.3% experienced zero turnover, more than for assigned champions. While champions in both groups received training, more champions in health systems reported being trained than those in clinics (75.8% vs 52.2%). No significant differences in EBIs implemented were observed between those clinics with and without a champion. Zero champion turnover was associated with great or very great leadership support (68.9%), program adaptation (60.7%) and organizational capacity (54.1%). Interviews found that champions' roles included advocating for CRC screening, providing technical assistance for EBI implementation, creating organizational policies for CRC screening, and overseeing QI. Interviewees reported a desire to address champion sustainability.
These findings inform the use of program champions for clinic-based public health programs. Naturally emerging champions were more stable than those assigned the role.
美国疾病控制与预防中心的结直肠癌控制项目(CRCCP)旨在通过在与该项目合作的卫生系统诊所实施循证干预措施(EBIs),提高结直肠癌(CRC)筛查的普及率。项目倡导者作为该项目的关键组成部分之一,有望以多种方式促进循证干预措施的实施,并支持所需的变革。鉴于临床系统中关于倡导者的信息有限,本研究调查了CRCCP中的倡导者类型、角色和可持续性。
这项混合方法的横断面研究包括对代表303家诊所的205名受访者(卫生系统和诊所工作人员)进行的调查,以及对CRCCP获奖者和合作诊所进行的12次定性访谈。该调查评估了诊所特征、循证干预措施的实施情况、关于项目倡导者的信息以及可持续性。访谈主题包括倡导者的角色、益处、更替情况和维持情况。
倡导者在卫生系统或诊所层面工作。在卫生系统中,倡导者是质量改进(QI)经理(48.5%)、医生(36.4%)或高级管理人员(27.3%)。在诊所中,倡导者是医生(37.0%)、QI经理(26.1%)或医疗助理(23.9%)。卫生系统和诊所中的倡导者最常被赋予该角色(分别为45.5%和45.7%);然而,诊所倡导者比卫生系统倡导者更有可能自然产生(26.1%对15.2%)。在自然产生的倡导者中,64.3%的人更替率为零,高于被指定的倡导者。虽然两组倡导者都接受了培训,但卫生系统中接受培训的倡导者比诊所中的更多(75.8%对52.2%)。在有和没有倡导者的诊所之间,在实施循证干预措施方面未观察到显著差异。倡导者零更替与极大或非常大的领导支持(68.9%)、项目适应性(60.7%)和组织能力(54.1%)相关。访谈发现,倡导者的角色包括倡导结直肠癌筛查、为循证干预措施的实施提供技术援助、制定结直肠癌筛查的组织政策以及监督质量改进。受访者表示希望解决倡导者的可持续性问题。
这些发现为基于诊所的公共卫生项目中项目倡导者的使用提供了参考。自然产生的倡导者比被指定的倡导者更稳定。